Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Others

Items 61-70 of 106

Page
per page
  1. T0901317
    A2249 T0901317
    Target: Liver X receptors (LXRs)
    Summary: Liver X receptor agonist,potent and selective
      ≥24.05 mg/mL
  2. SC 144
    A2173 SC 144
     1 Citation
    Target: Glycoproteins
    Summary: Gp130 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.1 mg/mL
  3. Verteporfin
    A8327 Verteporfin
    Target: YAP
    Summary: Photosensitizer used in photodynamic therapy
      insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
  4. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM kinase II inhibitor, water soluble and cell permeable
      ≥29.95 mg/mL
  5. BPTES
    B6008 BPTES
    Target: Glutaminases
    Summary: GLS inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18 mg/mL
  6. Disodium (R)-2-Hydroxyglutarate
    B6018 Disodium (R)-2-Hydroxyglutarate
    Summary: inhibitor of α-ketoglutarate-dependent dioxygenases
      insoluble in EtOH; insoluble in DMSO; ≥9.1 mg/mL
  7. Sodium Tauroursodeoxycholate (TUDC)
    B6019 Sodium Tauroursodeoxycholate (TUDC)
    Target: BCPCF efflux
    Summary: water soluble bile salt
      ≥26.1 mg/mL
  8. 680C91
    B5573 680C91
    Summary: tryptophan 2,3-dioxygenase (TDO) inhibitor
      Soluble in DMSO
  9. KL 001
    B5684 KL 001
    Target: Cryptochromes
    Summary: cryptochrome protein (CRY) stabilizer
      Soluble in DMSO
  10. SR 2211
    B5743 SR 2211
    Target: Retinoic acid-related Orphan Receptors (RORs)
    Summary: inverse agonist of RORγ, potent and selective
      Soluble in DMSO

Items 61-70 of 106

Page
per page
Relate Categories
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Category
  1. Actin 2item
  2. Adenylate cyclase 1 item
  3. ATP citrate lyase 1 item
  4. Calmodulin protein kinase II 1 item
  5. CaM kinase II 6item
  6. Cytokine 1 item
  7. DHODH 1 item
  8. FBPase 1 item
  9. FXR 2item
  10. Glycoprotein 1 item
  11. GSNOR 1 item
  12. GSTP1-1 1 item
  13. Guanylyl Cyclase 1 item
  14. Hydroxylases 1 item
  15. IMPDH 1 item
  16. Inositol Phosphatases 2item
  17. LXR 2item
  18. MDR multidrug resistance 1 item
  19. NAE 2item
  20. NADPH Oxidase 1 item
  21. Nampt 1 item
  22. Nuclear Receptors 3item
  23. Oxygenases/Oxidases 1 item
  24. PDHK 1 item
  25. RAR/RXR 5item
  26. RARs 4item
  27. Reagents 4item
  28. Renin 1 item
  29. Retinoid X Receptors 1 item
  30. Squalene epoxidase 2item
  31. SGK 2item
  32. SPHK 1 item
  33. Synthases/Synthetases 1 item
  34. Thymidine phosphorylase 1 item
  35. Transcription Factors 3item
  36. β(1,3)-D-Glucan Synthase 2item
  37. XAO 1 item
  38. Others 42item
  39. Renal Diseases 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 2item
Target
  1. Glycoproteins 1 item
  2. AP-1 1 item
  3. MMP 2item
  4. Thymidine Phosphorylases 1 item
  5. Voltage-gated Potassium (KV) Channels 1 item
  6. Farnesoid X receptors (FXRs) 1 item
  7. P-glycoprotein (P-gp) 1 item
  8. SGK 2item
  9. Liver X receptors (LXRs) 2item
  10. Neuraminidases (NA) 1 item
  11. RARs 8item
  12. ATP Citrate Lyases 1 item
  13. Microtubules/Tubulins 1 item
  14. Inositol Phosphatases 1 item
  15. FAK 1 item
  16. AMPK 1 item
  17. Gutathione S-transferase 1 item
  18. PDHK 1 item
  19. eIF4E/eIF3G interaction 1 item
  20. S-nitrosoglutathione reductase 1 item
  21. Topoisomerases 1 item
  22. Cytochrome P450 (CYP450) 1 item
  23. Renin 1 item
  24. Actin 2item
  25. BMI-1 1 item
  26. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  27. MLK3 1 item
  28. Protease-Activated Receptors 1 item
  29. Calcium chelator 1 item
  30. Sphingosine kinases (SphKs) 1 item
  31. BCPCF efflux 1 item
  32. D1 and D5 Receptors 1 item
  33. D2 Receptors 1 item
  34. D3 Receptors 1 item
  35. Pancreatic and duodenal homeobox 1 (PDX1) 1 item
  36. Angiotensin-Converting Enzymes (ACEs) 1 item
  37. ROS and Other Gaseous Donors 1 item
  38. C5a receptors 1 item
  39. YAP 1 item
  40. Cryptochromes 1 item
  41. Squalene epoxidases 2item
  42. Nampt 1 item
  43. eIF4F 1 item
  44. P2X Receptors 1 item
  45. Glutaminases 1 item
  46. Carbonic Anhydrases 2item
  47. BLM 1 item
  48. NADPH Oxidases 2item
  49. Synthases/Synthetases 2item
  50. TAK1 1 item
  51. Histamine H1 Receptors 1 item
  52. RAR/RXR 1 item
  53. Ionophores 1 item
  54. Xanthine oxidoreductases 1 item
  55. Dihydroorotate dehydrogenase 1 item
  56. Guanylyl Cyclases 1 item
  57. MNK 1 item
  58. eEF-2 1 item
  59. Inward Rectifier Potassium (Kir) Channels 1 item
  60. calcium chelator 1 item
  61. Nuclear Receptors 1 item
  62. fibrinolysis 1 item
  63. D4 Receptors 1 item
  64. Aldosterone receptor 1 item
  65. NAE 2item
  66. Ubiquitin-activating Enzyme E1 1 item
  67. SUMOylation 1 item
  68. ATGL 1 item
  69. Adenylyl Cyclases 1 item
  70. Retinoic acid-related Orphan Receptors (RORs) 1 item
  71. STK 1 item
  72. Rev-Erb Receptors 1 item
  73. Retinoid X receptors (RXR) 1 item
  74. SHIP 1 item
  75. FXR 1 item
Reported Experiments
  1. Animal Experiments 93item
  2. Cell Experiments 69item
Related Disease
  1. Abscesses And Esophageal Candidiasis 1 item
  2. Acute Disseminated Candidiasis 1 item
  3. Acute Myeloid Leukemia 2item
  4. Bladder Cancer 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 6item
  7. Cancer 34item
  8. Candida Peritonitis 1 item
  9. Candidemia 1 item
  10. Colon Cancer 5item
  11. Colorectal Cancer 4item
  12. Diabetes 1 item
  13. Dyslipidemia 1 item
  14. Fungal Infection 1 item
  15. Glioblastoma 2item
  16. Glioma 1 item
  17. Hepatocellular Carcinoma 1 item
  18. HIV 2item
  19. Inflammatory Diseases 5item
  20. Leukemia 1 item
  21. Lung Cancer 4item
  22. Lymphoma 5item
  23. Melanoma 1 item
  24. Non-small Cell Lung Cancer 2item
  25. Ovarian Cancer 2item
  26. Pancreatic Cancer 1 item
  27. Prostate Cancer 1 item
  28. Psoriasis 1 item
  29. Rheumatoid Arthritis 1 item
  30. Schizophrenia 1 item
  31. Squamous Cell Carcinoma 1 item
  32. Type 2 Diabetes 3item